Standout Papers

Gabapentin and Pregabalin for Pain — Is Increased Prescribing a Cause for Concern? 2017 2026 2020 2023 240
  1. Gabapentin and Pregabalin for Pain — Is Increased Prescribing a Cause for Concern? (2017)
    Christopher W. Goodman, Allan S. Brett New England Journal of Medicine

Immediate Impact

1 from Science/Nature 30 standout
Sub-graph 1 of 15

Citing Papers

Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline
2024 Standout
Epidemiology and the Growing Epidemic of Food Allergy in Children and Adults Across the Globe
2024 Standout
2 intermediate papers

Works of Christopher W. Goodman being referenced

Race and Pharmacogenomics—Personalized Medicine or Misguided Practice?
2021
A Clinical Overview of Off-label Use of Gabapentinoid Drugs
2019
and 1 more

Author Peers

Author Last Decade Papers Cites
Christopher W. Goodman 42 173 34 111 108 10 478
James Kurz 61 188 29 78 124 9 498
Jane O’Rorke 62 200 7 86 147 11 452
Nancy Janiczek 81 3 102 98 7 470
Diane Chau 30 129 14 50 103 17 547
Paula Burger 87 4 134 100 9 538
Michele L. Matthews 34 241 56 76 140 16 497
Michelle Davitt 50 140 28 109 84 16 530
Bianca Hoban 17 278 8 96 289 7 540
Milena N. Mareva 37 170 50 46 71 8 451
Paul Di Capua 94 220 37 47 148 12 443

All Works

Loading papers...

Rankless by CCL
2026